Sun Pharma jumps 5% on series of clarifications

Shares of Sun Pharma jumped as much as 5.1 per cent to Rs 418.70 in the early trade on BSE after the company made a series of clarifications and changes in its filing to the bourses. 

The drug major said that its domestic formulations distribution shall be transitioned from Aditya Medisales, the current distributor, to a wholly-owned subsidiary of Sun Pharma and the change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals. CLICK HERE TO READ THE PRESS PRELEASE

This apart, the firm also announced unwinding of a transaction with Atlas Global